Else Nutrition to Present at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)

At its first appearance at NASPGHAN annual meeting, ELSE sets the stage for interaction with 2,600 North American medical experts.

VANCOUVER, BC, Nov. 2, 2020 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) ("Else" or the "Company"), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to announce that it will be participating at this year's NASPGHAN (North American Society for Pediatric Gastroenterology, Hepatology and Nutrition), November 1^st to 7^th.  Else's virtual booth will enable live conversations with small groups, and one-on-one educational sessions, among the nearly 2,600 anticipated attendees. The forum will place Else Nutrition alongside some of the leading blue-chip nutrition companies, including Pfizer, Abbott Laboratories, Nestle and Danone.

NASPGHAN Logo (CNW Group/Else Nutrition Holdings Inc.)

"We are working diligently to build awareness of our products with America's top pediatricians and medical experts" said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. "We want them to form their own unbiased opinion of ELSE's health benefits for babies and we are excited to introduce and promote our plant-based product to this professional crowd at NASPGHAN.  Educating the medical community is a major pillar of our marketing strategy," she added.

This year's annual summit is virtual due to COVID-19.

Else Nutrition's Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available for sale on Else's e-store at elsenutrition.com, and on Amazon.com.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean, plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition organizations. Many of Else advisory board  members held executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in prominent roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company's financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE Else Nutrition Holdings Inc.

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director, ELSE Nutrition Holdings Inc., E: [email protected], P: [phone]; Mr. Sokhie Puar, Director of Else Nutrition, Email: [email protected], Telephone: [phone]